D Van Der Heijde - Rheumazentrum Ruhrgebiet, Landgrafenstr. 15, 44652, Herne, Germany

基本信息

浏览量：303

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 243 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Pos1122 efficacy and safety of upadacitinib in patients with active ankylosing spondylitis and an inadequate response to biologic dmard therapy: one-year results from a phase 3 study

Xenofon Baraliakos,D. van der Heijde,Joachim Sieper,Robert D. Inman, H. Kameda, Y. LI, X. Bu, A. Shmagel, P. Wung,In‐Ho Song,Atul Deodhar

Annals of the Rheumatic Diseasesno. Suppl 1 (2023): 887.2-888

引用0浏览0引用

Effet du sécukinumab versus adalimumab biosimilaire sur la progression radiographique chez les patients atteints de spondyloarthrite axiale radiographique : analyse en sous-groupes avec sur le statut syndesmophytes et protéine C-réactive à l’inclusion

C. Roux, D. Poddubnyy,D. Van Der Heijde, D. Atul, P. Machado, V. Navarro-compán, K.G. Hermann, M. Kishimoto, E.Y. Lee, L. Gensler, U. Kiltz, M. Eigenman,

Revue du Rhumatisme (2023): A176

引用0浏览0引用

Clinical and radiographic results of tapering and withdrawing csDMARDs versus stable treatment in patients with rheumatoid arthritis in remission: 3-year results from a randomized controlled trial

K. Kjorholt, N. Sundlisaeter, A. Aga, J. Sexton, I. Olsen, H. Fremstad, C. Spada, T. Madland, C. Hoili, G. Bakland, A. Lexberg, I. Hansen,

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY（2023）

引用0浏览0引用

Pos0302 treating spondyloarthritis early: does it matter? results from a systematic literature review

Dafne Capelusnik, D. Benavent,D. van der Heijde, R. Landewé, D. Poddubnyy,Astrid van Tubergen, L. Falzon, V. Navarro-Compán, S. Ramiro

Annals of the Rheumatic Diseasesno. Suppl 1 (2022): 399.2-400

引用0浏览0引用

DEVELOPMENT OF PREDICTION MODELS FOR SENIOR PATIENTS WITH RHEUMATOID ARTHRITIS AND COMORBIDITIES TREATED WITH CHRONIC LOW-DOSE GLUCOCORTICOIDS IN THE GLORIA TRIAL

L. Hartman,J. A. P. Da Silva, F. Buttgereit,M. Cutolo, D. Opris-Belinski,Z. Szekanecz, P. Masaryk,M. Voshaar, M. W. Heijmans, W. Lems,D. Van der Heijde,M. Boers

ANNALS OF THE RHEUMATIC DISEASES（2022）

引用0浏览0引用

OP0019 BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 2, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY

D. Van der Heijde, X. Baraliakos, M. Dougados, M. Brown, D. Poddubnyy,F. Van den Bosch, N. Haroon, H. Xu, T. Tomita, L. S. Gensler, M. Oortgiesen, C. Fleurinck,

Annals of the Rheumatic Diseasesno. Suppl 1 (2022): 12-13

引用0浏览0引用

Efficacité et tolérance d’upadacitinib chez des patients atteints de spondylarthrite ankylosante et ayant eu une intolérance et/ou un manque d’efficacité lors d’un traitement antérieur par biologique : analyse en sous-groupes

X. Baraliakos, F. Ganz, H. Kameda, J.A. Walsh, M. Jain, K. D'silva, P. Wung, X. Bu, J. Stigler, P. Goupille,D. Van Der Heijde

Revue du Rhumatisme（2022）

引用0浏览0引用

Pos0963 how is early spondyloarthritis defined in the literature? results from a systematic review

D. Benavent, D. Capelusnik,D. Van der Heijde, R. B. M. Landewé, D. Poddubnyy,A. Van Tubergen, L. Falzon, S. Ramiro, V. Navarro-Compán

Annals of the Rheumatic Diseasesno. Suppl 1 (2022): 787.1-788

引用0浏览0引用

Pos1410 development of prediction models for senior patients with rheumatoid arthritis and comorbidities treated with chronic low-dose glucocorticoids in the gloria trial

L. Hartman,J. A. P. Da Silva, F. Buttgereit, M. Cutolo, D. Opris-Belinski, Z. Szekanecz, P. Masaryk, M. Voshaar, M. W. Heijmans, W. Lems,D. Van der Heijde, M. Boers

Annals of the Rheumatic Diseasesno. Suppl 1 (2022): 1047.1-1047

引用0浏览0引用

DO FATTY LESIONS EXPLAIN THE ASSOCIATION BETWEEN INFLAMMATION AND NEW SYNDESMOPHYTES IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS

R. Stal,A. Sepriano, S. Ramiro,F. A. van Gaalen,P. Machado,X. Baraliakos,R. van den Berg, M. Reijnierse,J. Braun, R. B. M. Landewe,D. van der Heijde

ANNALS OF THE RHEUMATIC DISEASES（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn